SARS-CoV-2 neutralizing antibody bebtelovimab - a systematic scoping review and meta-analysis.
Frontiers in immunology（2023）
Abstract
Preclinical evidence suggests bebtelovimab be a potential treatment for COVID-19 amidst viral evolution. Bebtelovimab has comparable efficacy to other COVID-19 therapies without evident safety concerns.
MoreTranslated text
Key words
antibody bebtelovimab,sars-cov,meta-analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined